According to the NHS, MS presents in several forms, including relapsing-remitting MS (the most common type, characterised by periods of symptoms followed by partial or complete recovery), secondary progressive MS (where disability gradually worsens), and primary progressive MS (steady progression from onset)
Epilepsia 54:983989
Circ J (2016) 80(11):227781
If you have diagnosed moderate-to-severe obstructive sleep apnea, a BMI of 30 or higher, documented CPAP failure, and an A1C of 6.5% or lower, you may qualify for Zepbound coverage through the sleep apnea indication even if your plan excludes weight loss medications
and no, we dont just mean eating less
In the overweight/obese cohort, there was a 6.7% incidence of NAION events in the semaglutide group and 0.8% % in the nonGLP-1R agonist cohort